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INTRODUCTION. Burn patients with inhalation injury requiring mechanical ventilation 
(MV) are at particular risk for ventilator-associated pneumonia (VAP). Routine endotracheal 
surveillance cultures (SC) may provide information about the causative pathogen in 
subsequent VAP, and hence contribute to high rates of early appropriate antibiotic therapy 
[1]. 
OBJECTIVES. To assess the value of routine endotracheal SC to predict multidrug resistant 
(MDR) etiology of VAP in burn patients with inhalation injury. 
METHODS. We performed a historical cohort study including all burn patients with 
inhalation injury requiring MV admitted to the burn unit at Ghent University Hospital (2002-
2009). Routine endotracheal SC are sampled thrice weekly. Only results of the last SC before 
VAP onset were considered. VAP was diagnosed on clinical, radiological, and 
microbiological grounds, and supported by a Clinical Pulmonary Infection Score (CPIS) >6. 
RESULTS. 53 patients were included. Median age and total burned surface area were 44y 
(IQR 39-55y) and 35% (IQR 19-50%) respectively. The median Belgian Outcome in Burn 
Injury score was 5 (IQR, 4-6), reflecting a predicted mortality of 30% (IQR 20-50%) [2]. 
Overall, 70 episodes of VAP occurred in 46 patients (86.8%). Median duration of MV prior 
to onset VAP was 7 days (IQR 4-9 days). The incidence of VAP was 55 episodes/1000 MV 
days and112 episodes/1000 MV days "at risk". The median CPIS was 8 (IQR 6-9). Most 
prevalent pathogens were Pseudomonas aeruginosa (39.8%), Staphylococcus aureus 
(12.9%), and Enterobacter spp (10.8%). In 23 episodes (32.9%) at least one MDR causative 
pathogen was involved, mostly MDR P. aeruginosa and ESBL-producing 
Enterobacteriaceae. The sensitivity and specificity of SC to predict MDR pathogens in 
subsequent VAP was respectively 0.83 and 0.96. This corresponds with a positive predictive 
value (PPV) of 0.87 and a negative predictive value (NPV) of 0.95. A subgroup analysis was 
performed on P. aeruginosa (37 episodes). The sensitivity and specificity of SC to predict 
MDR P. aeruginosa was 0.90 and 0.99, respectively. The PPV and NPV was 0.90 and 0.99 
respectively.  
CONCLUSIONS. The incidence of VAP in burn patients with inhalation injury is high. In 
this cohort routine SC appear to have excellent operating characteristics to predict MDR 
involvement in VAP.  
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